aminopropionitrile has been researched along with Bronchopulmonary Dysplasia in 1 studies
Aminopropionitrile: Reagent used as an intermediate in the manufacture of beta-alanine and pantothenic acid.
Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mižíková, I | 1 |
| Ruiz-Camp, J | 1 |
| Steenbock, H | 1 |
| Madurga, A | 1 |
| Vadász, I | 1 |
| Herold, S | 1 |
| Mayer, K | 1 |
| Seeger, W | 1 |
| Brinckmann, J | 1 |
| Morty, RE | 1 |
1 other study available for aminopropionitrile and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Collagen and elastin cross-linking is altered during aberrant late lung development associated with hyperoxia.
Topics: Aminopropionitrile; Animals; Bronchopulmonary Dysplasia; Collagen; Elastin; Extracellular Matrix; Hy | 2015 |